Diagnosing a dangerous infection by a fungal yeast that often devastates hospital patients is now faster and more efficient. The new blood test has the potential to improve patient outcomes, as the ...

LEXINGTON, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the ...

What Are the Symptoms of Invasive Candidiasis? People who have other medical conditions are often at risk of getting invasive candidiasis. It can be difficult to tell which symptoms are caused by ...

Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision. That decision relies on susceptibility testing, but commercially available ...

Arif R. Sarwari does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

The FDA authorized the first test April 20 to identify emerging pathogen Candida auris, which can lead to serious infections in hospitalized patients. In particular, the agency approved marketing for ...

T2 Biosystems (NASDAQ:TTOO) confirmed its plans to add detection of fungal pathogen Candida auris to its FDA-cleared and CE marked T2Candida Panel. A rare and often deadly fungal species is spreading ...

Cases of the drug-resistant fungus Candida auris are now climbing at an "alarming" rate in health care facilities around the country, the Centers for Disease Control and Prevention warned Monday, ...

* U.S. FDA SAYS PERMITTED MARKETING FOR A NEW USE OF THE BRUKER MALDI BIOTYPER CA SYSTEM FOR THE IDENTIFICATION OF CANDIDA AURIS * U.S. FDA SAYS FDA GRANTED MARKETING AUTHORIZATION OF THE TEST TO ...